James Francis Smith

This profile gathers the share dealings of James Francis Smith across 2 companies, led by Echo Therapeutics, Inc. and Orchid Cellmark Inc. We count 13 filings; the first trade dates from 5 August 2008 and the latest from 18 December 2013.

Every open-market trade on record is a purchase: 3 purchases worth €30k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 9 share grants.

A typical purchase (the median) is worth €7,490.

Most recently, on 3 January 2014, the filings show a share grant in Echo Therapeutics, Inc. The clock since the last published purchase (23 August 2012) now reads 5,175 days. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.